Opexa presentation.
Posted: Fri Apr 16, 2010 5:06 am
... in the .pdf file, the "abstract" section, last line:
A larger study of Tovaxin is merited and planned, with recruitment targeting RR-MS patients with ARR≥1.
This Is MS Multiple Sclerosis Knowledge & Support Community
Welcome to This is MS, the leading forum for Multiple Sclerosis research and support. Join our friendly community of patients, caregivers, and researchers celebrating over 20 years of delivering hope through knowledge.
https://www.thisisms.com/forum/
Opexa presentation.
Page 1 of 1
On the Opexa homepage...
Posted: Wed Apr 21, 2010 11:07 pm
... down there in that section where we can read the latest stuff about the Poster Session...
... in the .pdf file, the "abstract" section, last line:
A larger study of Tovaxin is merited and planned, with recruitment targeting RR-MS patients with ARR≥1.
... in the .pdf file, the "abstract" section, last line:
A larger study of Tovaxin is merited and planned, with recruitment targeting RR-MS patients with ARR≥1.
Posted: Sat Apr 24, 2010 6:34 pm
I don't want to get too exited, but hey! They have a history of bringing down though. Thought I would share and let people weed thought as needed.